Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Change in Inventory (2019 - 2022)

VYNE Therapeutics' Change in Inventory history spans 4 years, with the latest figure at -$97000.0 for Q1 2022.

  • For Q1 2022, Change in Inventory fell 114.1% year-over-year to -$97000.0; the TTM value through Dec 2022 reached -$97000.0, up 14.16%, while the annual FY2022 figure was -$97000.0, 14.16% up from the prior year.
  • Change in Inventory reached -$97000.0 in Q1 2022 per VYNE's latest filing, up from -$779000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.6 million in Q2 2020 to a low of -$779000.0 in Q4 2021.
  • Average Change in Inventory over 4 years is $719400.0, with a median of $721000.0 recorded in 2020.
  • Peak YoY movement for Change in Inventory: tumbled 44.4% in 2020, then plummeted 203.32% in 2021.
  • A 4-year view of Change in Inventory shows it stood at $1.4 million in 2019, then crashed by 44.4% to $754000.0 in 2020, then tumbled by 203.32% to -$779000.0 in 2021, then soared by 87.55% to -$97000.0 in 2022.
  • Per Business Quant, the three most recent readings for VYNE's Change in Inventory are -$97000.0 (Q1 2022), -$779000.0 (Q4 2021), and -$209000.0 (Q3 2021).